Sweeny Nicole
Chief Commercial Officer
Sweeny Nicole has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.
On the most recent filing, Sweeny Nicole is listed as Chief Commercial Officer at KalVista Pharmaceuticals, Inc. Inside the rolling window, Sweeny Nicole reported no open-market purchases and 5 open-market sales totaling $241K in KALV. The largest disclosed transaction in the window is a sale of 3,975 KALV shares on Feb 23, 2026, worth $62K.
Companies traded
Other insiders at KALV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$241K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sweeny Nicole made?
Sweeny Nicole has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Sweeny Nicole trade?
Sweeny Nicole has filed SEC Form 4 disclosures for 1 company, including KALV.
When was Sweeny Nicole's most recent SEC Form 4 filing?
Sweeny Nicole's most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.
What is Sweeny Nicole's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sweeny Nicole is listed as Chief Commercial Officer.
What is Sweeny Nicole's total buy and sell value in the current window?
Inside the rolling retention window, Sweeny Nicole bought $0 and sold $241K based on SEC Form 4 filings.
What was Sweeny Nicole's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,975 KALV shares on 2026-02-23, worth $62K, per SEC Form 4 filings.